Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Orgenesis Inc (ORGS)

Orgenesis Inc (ORGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Orgenesis Provides Third Quarter 2024 Business Update GlobeNewswire - Wed Nov 13, 7:00AM CST

ORGS : 1.3000 (-7.14%)
Orgenesis Commences Trading on OTCQX® Best Market GlobeNewswire - Mon Oct 21, 7:00AM CDT

ORGS : 1.3000 (-7.14%)
Orgenesis Achieves Revenue of $7.2 Million for the First Quarter of 2022 Globe Newswire - Tue May 24, 2022

GERMANTOWN, Md., May 24, 2022 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to...

ORGS : 1.3000 (-7.14%)
Orgenesis Led Consortium Awarded €4M European Innovation Council Pathfinder Grant Globe Newswire - Tue May 3, 2022

Focus is to Develop Cost-effective Production of Autologous Induced Pluripotent Stem Cells (iPSCs) using Microfluidic Technologies and Artificial...

ORGS : 1.3000 (-7.14%)
Orgenesis Reports Revenue Growth of 364% for 2021 and Provides Business Update Globe Newswire - Wed Mar 30, 2022

Orgenesis to host conference call today at 12:00 PM ET...

ORGS : 1.3000 (-7.14%)
Orgenesis reaches next milestone in collaboration with Hospital Infantil Universitario Niño Jesús in Madrid Globe Newswire - Thu Jan 27, 2022

Orgenesis achieves milestone in the placement of the Orgenesis Mobile Processing Units and Lab (OMPUL) for the development of cell and gene therapies at...

ORGS : 1.3000 (-7.14%)
Orgenesis and Johns Hopkins University expand POCare in Maryland through creation of the Maryland Center for Cell Therapy Manufacturing Globe Newswire - Tue Jan 18, 2022

Center will expand Orgenesis’ Point of Care (POCare) Platform Capabilities in Maryland...

ORGS : 1.3000 (-7.14%)
Orgenesis Reports 425% Increase in Revenue for the Third Quarter of 2021 Compared to Same Period Last Year Globe Newswire - Thu Nov 4, 2021

Orgenesis to host conference call today at 8:30AM ET...

ORGS : 1.3000 (-7.14%)
Orgenesis Schedules Third Quarter 2021 Business Update Conference Call Globe Newswire - Tue Nov 2, 2021

GERMANTOWN, Md., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to...

ORGS : 1.3000 (-7.14%)
Orgenesis Announces Collaboration Agreement with Savicell to License and Deploy its ImmunoBiopsy™ Platform Globe NewsWire - Mon Aug 23, 2021

Goal to accelerate development, QC testing and manufacturing  of Orgenesis’ cell and gene therapy platform

ORGS : 1.3000 (-7.14%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot